Immunoassays are crucial for accurately measuring analytes in complex biological samples, making them indispensable in drug discovery and development. At Q2 Solutions, we harness extensive expertise in bioanalytical method development and testing to design and validate immunoassays. Our approach adheres to industry best practices and regulatory standards, ensuring robust results. Annually, we analyze over one million bioanalytical samples, supporting biosimilar, pharmacokinetic (PK), immunogenicity (e.g., anti-drug antibody assays), and neutralizing antibody assays.
From method development, validation, and sample analysis to comprehensive management and medical writing support, Q2 Solutions offers a complete spectrum of bioanalytical services. We specialize in developing and validating ligand-binding assays for various therapeutic products, including:
- ADCs (Antibody Drug Conjugates)
- AVV
- CAR-T
- Bi-specific/tri-specific antibodies
- Bi-functional proteins
- Fusion antibodies/proteins
- Monoclonal antibodies
- Oligonucleotides
- Pegylated molecules
